BRPI0907340A2 - "sistema de expressão de peptídeos sobre a superfície bacteriana, construção genética, plasmídeo, método para elaborar o sistema de expressão de peptídeos, peptídeo recombinante, uso do sistema de expressão e uso do peptídeo recombinante" - Google Patents

"sistema de expressão de peptídeos sobre a superfície bacteriana, construção genética, plasmídeo, método para elaborar o sistema de expressão de peptídeos, peptídeo recombinante, uso do sistema de expressão e uso do peptídeo recombinante"

Info

Publication number
BRPI0907340A2
BRPI0907340A2 BRPI0907340A BRPI0907340A BRPI0907340A2 BR PI0907340 A2 BRPI0907340 A2 BR PI0907340A2 BR PI0907340 A BRPI0907340 A BR PI0907340A BR PI0907340 A BRPI0907340 A BR PI0907340A BR PI0907340 A2 BRPI0907340 A2 BR PI0907340A2
Authority
BR
Brazil
Prior art keywords
peptide
expression system
recombinant
plasmid
recombinant peptide
Prior art date
Application number
BRPI0907340A
Other languages
English (en)
Inventor
José De La Fuente García
Mario Manuel Canales García-Menocal
Original Assignee
Consejo Superior Investigacion
Univ Castilla La Mancha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion, Univ Castilla La Mancha filed Critical Consejo Superior Investigacion
Publication of BRPI0907340A2 publication Critical patent/BRPI0907340A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Insects & Arthropods (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0907340A 2008-04-16 2009-04-16 "sistema de expressão de peptídeos sobre a superfície bacteriana, construção genética, plasmídeo, método para elaborar o sistema de expressão de peptídeos, peptídeo recombinante, uso do sistema de expressão e uso do peptídeo recombinante" BRPI0907340A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200801129A ES2352946B1 (es) 2008-04-16 2008-04-16 Sistema para la expresión de péptidos sobre la superficie bacteriana.
PCT/ES2009/070103 WO2009127766A1 (es) 2008-04-16 2009-04-16 Sistema para la expresión de péptidos sobre la superficie bacteriana

Publications (1)

Publication Number Publication Date
BRPI0907340A2 true BRPI0907340A2 (pt) 2016-07-05

Family

ID=41198810

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907340A BRPI0907340A2 (pt) 2008-04-16 2009-04-16 "sistema de expressão de peptídeos sobre a superfície bacteriana, construção genética, plasmídeo, método para elaborar o sistema de expressão de peptídeos, peptídeo recombinante, uso do sistema de expressão e uso do peptídeo recombinante"

Country Status (7)

Country Link
US (1) US8435537B2 (pt)
EP (1) EP2281893B1 (pt)
BR (1) BRPI0907340A2 (pt)
CO (1) CO6311116A2 (pt)
ES (1) ES2352946B1 (pt)
MX (1) MX2010011384A (pt)
WO (1) WO2009127766A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102013026625B1 (pt) 2013-10-16 2022-04-26 Universidade Federal de Viçosa Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0001717B1 (pt) * 2000-05-04 2013-10-08 Vacina sintética para o controle de carrapatos
US6979451B1 (en) * 2000-10-30 2005-12-27 The Board Of Regents For Oklahoma State University Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

Also Published As

Publication number Publication date
CO6311116A2 (es) 2011-08-22
EP2281893A1 (en) 2011-02-09
MX2010011384A (es) 2011-04-12
EP2281893B1 (en) 2016-05-04
WO2009127766A1 (es) 2009-10-22
EP2281893A4 (en) 2012-10-31
ES2352946B1 (es) 2012-01-23
ES2352946A1 (es) 2011-03-07
US20110097354A1 (en) 2011-04-28
US8435537B2 (en) 2013-05-07

Similar Documents

Publication Publication Date Title
BR112012011931A2 (pt) "sistema de distribuição e embalagem para uso conjunto "
DE602007001160D1 (de) Führungssystem zum Abbiegen auf Lande- und Rollbahnen
BRPI0817299A2 (pt) Vacinas e componentes de vacina para inibição de células microbianas
BRPI0820812A2 (pt) Sistema e métodos de entrega de material
DK2520168T3 (da) Målrettet gen-tilførsel til dendrit-cellevaccination
BRPI0812920A2 (pt) Sistema de expressão de celulase heteróloga e homóloga
PL1976559T6 (pl) Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
HK1200180A1 (en) Recombinant vaccine against bluetongue virus
IL195683A0 (en) Recombinant viral vaccine
BRPI0819492A2 (pt) "sistema de resfriamento e método para desviar um reservatório em um sistema de resfriamento"
BRPI0816151A2 (pt) válvula utilizável com um poço, sistema usável com um poço, e método usável com um poço
ATE518958T1 (de) Zur impfung verwendetes papillomavirus-e2- polypeptid
EP2091960A4 (en) PEPTIDE VACCINE AGAINST INFLUENZA VIRUS
BRPI0812626A2 (pt) "sistema modular e método para detectar microorganismos"
BRPI0916016A2 (pt) "atuador pneumático, e sistema e método para controle deste"
BRPI0816778A2 (pt) Sistema de infusão e transferência para uso com agentes radioativos
HK1125315A1 (en) Recombinant attenuated clostridium organisms and vaccine
BRPI0905913A2 (pt) "polipeptídeos, composição para detectar um microorganismo alvo e métodos para detectar um microorganismo alvo"
DK2133416T3 (da) Rekombinant mikroorganisme
BRPI0714762A2 (pt) Meios e métodos de aumento de entrega para sistemas biológicos
BRPI0713842A2 (pt) sistema intrauterino recuperável
BRPI0721398A2 (pt) "sistema de colaboração de midia e método de colaboração de midia"
ITMI20061321A1 (it) Apparato semovente di pulizia per strade e aree urbane
BRPI0907340A2 (pt) "sistema de expressão de peptídeos sobre a superfície bacteriana, construção genética, plasmídeo, método para elaborar o sistema de expressão de peptídeos, peptídeo recombinante, uso do sistema de expressão e uso do peptídeo recombinante"
BRPI0909540A2 (pt) ''sistema de injeção de combustível''

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNIVERSIDAD DE CASTILLA LA MANCHA (ES)

B25G Requested change of headquarter approved

Owner name: UNIVERSIDAD DE CASTILLA LA MANCHA (ES)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]